Stratification | ASD (n) | Non-ASD (n) | AUC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) |
---|---|---|---|---|---|
ADI-R | |||||
Full sample | 9 | 54 | 0.97 (0.93–1) | 1.00 (0.66–1.00) | 0.87 (0.75–0.95) |
CBCL externalizing | |||||
< 64 | 6 | 33 | 0.98 (0.96–1) | 1.00 (0.54–1.00) | 0.91 (0.76–0.98) |
≥ 64 | 3 | 19 | 0.95 (0.84–1) | 1.00 (0.29–1.00) | 0.84 (0.60–0.97) |
CBCL internalizing | |||||
< 64 | 4 | 32 | 1 (1–1) | 1.00 (0.40–1.00) | 0.91 (0.75–0.98) |
≥ 64 | 5 | 20 | 0.93 (0.82–1) | 1.00 (0.48–1.00) | 0.85 (0.62–0.97) |
ADOS-2 | |||||
Full sample | 9 | 53 | 0.97 (0.93–1) | 0.89 (0.52–1.00) | 0.98 (0.90–1.00) |
CBCL externalizing | |||||
< 64 | 6 | 32 | 0.99 (0.96–1) | 1.00 (0.54–1.00) | 1.00 (0.89–1.00) |
≥ 64 | 3 | 19 | 0.92 (0.79–1) | 0.67 (0.09–0.99) | 0.90 (0.74–1.00) |
CBCL internalizing | |||||
< 64 | 4 | 31 | 1 (1–1) | 1.00 (0.40–1.00) | 1.00 (0.89–1.00) |
≥ 64 | 5 | 20 | 0.91 (0.79–1) | 0.80 (0.28–0.99) | 0.91 (0.75–1.00) |
SRS-2 | |||||
Full sample | 9 | 52 | 0.85 (0.75–0.96) | 1.00 (0.66–1.00) | 0.59 (0.45–0.73) |
CBCL externalizing | |||||
< 64 | 6 | 33 | 0.92 (0.82–1) | 1.00 (0.54–1.00) | 0.69 (0.51–0.84) |
≥ 64 | 3 | 19 | 0.72 (0.51–0.93) | 1.00 (0.29–1.00) | 0.42 (0.21–0.67) |
CBCL internalizing | |||||
< 64 | 4 | 32 | 0.96 (0.89–1) | 1.00 (0.40–1.00) | 0.75 (0.57–0.89) |
≥ 64 | 5 | 20 | 0.68 (0.44–0.91) | 1.00 (0.48–1.00) | 0.36 (0.15–0.59) |
SCQ | |||||
Full sample | 9 | 52 | 0.85 (0.73–0.96) | 0.78 (0.40–0.97) | 0.73 (0.61–0.85) |
CBCL externalizing | |||||
< 64 | 6 | 33 | 0.86 (0.72–1.00) | 0.66 (0.22–0.95) | 0.76 (0.58–0.89) |
≥ 64 | 3 | 19 | 0.80 (0.60–1.00) | 1.00 (0.29–1.00) | 0.68 (0.43–0.87) |
CBCL internalizing | |||||
< 64 | 4 | 32 | 0.90 (0.80–1.00) | 1.00 (0.40–1.00) | 0.81 (0.64–0.93) |
≥ 64 | 5 | 20 | 0.77 (0.56–0.98) | 0.60 (0.15–0.95) | 0.60 (0.36–0.81) |